NanoViricides (NYSE:NNVC) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of NanoViricides (NYSE:NNVC – Free Report) in a research report sent to investors on Friday. The firm issued a sell rating on the stock. NanoViricides Stock Down 7.7 % NanoViricides stock opened at $1.20 on Friday. NanoViricides has a 52 week low of $1.04 and a 52 week high of […]

Related Keywords

,Sigma Securities ,Herpecide Program Expansion Drug ,Renaissance Technologies ,Nanoviricides Inc ,Millennium Management ,Free Report ,Viricides Stock Down ,Sigma Investments ,Get Free Report ,Monkeypox Treatment ,Nanoviricides Daily ,Nanoviricides ,Nyse Nnvc ,Nnvc ,Medical ,Initiated Coverage ,Stocknews Com ,